| Multi‐layered stochasticity and paracrine signal propagation shape the type‐I interferon response U Rand, M Rinas, J Schwerk, G Nöhren, M Linnes, A Kröger, M Flossdorf, ... Molecular systems biology 8 (1), 584, 2012 | 175 | 2012 |
| IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction A Stirnweiss, A Ksienzyk, K Klages, U Rand, M Grashoff, H Hauser, ... The Journal of Immunology 184 (9), 5179-5185, 2010 | 145 | 2010 |
| Temporal and Spatial Resolution of Type I and III Interferon Responses In Vivo JE Pulverer, U Rand, S Lienenklaus, D Kugel, N Zietara, G Kochs, ... Journal of virology 84 (17), 8626-8638, 2010 | 124 | 2010 |
| SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface F Bertoglio, D Meier, N Langreder, S Steinke, U Rand, L Simonelli, ... Nature communications 12 (1), 1577, 2021 | 82 | 2021 |
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations F Bertoglio, V Fühner, M Ruschig, PA Heine, L Abassi, T Klünemann, ... Cell reports 36 (4), 2021 | 74 | 2021 |
| Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency F Dağ, L Dölken, J Holzki, A Drabig, A Weingärtner, J Schwerk, ... PLoS pathogens 10 (2), e1003962, 2014 | 65 | 2014 |
| The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting MM Zimmer, A Kibe, U Rand, L Pekarek, L Ye, S Buck, RP Smyth, ... Nature communications 12 (1), 7193, 2021 | 59 | 2021 |
| Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations H Jacobsen, M Strengert, H Maaß, MA Ynga Durand, M Katzmarzyk, ... Scientific reports 12 (1), 19858, 2022 | 35 | 2022 |
| Structure determination of helical filaments by solid-state NMR spectroscopy L He, B Bardiaux, M Ahmed, J Spehr, R König, H Lünsdorf, U Rand, ... Proceedings of the National Academy of Sciences 113 (3), E272-E281, 2016 | 29 | 2016 |
| Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies C Pommerenke, U Rand, CC Uphoff, S Nagel, M Zaborski, V Hauer, ... PloS one 16 (8), e0255622, 2021 | 26 | 2021 |
| Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication in vitro through stimulation of innate immunity U Rand, SY Kupke, H Shkarlet, MD Hein, T Hirsch, P Marichal-Gallardo, ... Cells 10 (7), 1756, 2021 | 23 | 2021 |
| Type I interferon released by myeloid dendritic cells reversibly impairs cytomegalovirus replication by inhibiting immediate early gene expression JK Holzki, F Dağ, I Dekhtiarenko, U Rand, R Casalegno-Garduño, S Trittel, ... Journal of virology 89 (19), 9886-9895, 2015 | 23 | 2015 |
| Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors B Kasmapour, T Kubsch, U Rand, B Eiz-Vesper, M Messerle, ... Journal of virology 92 (1), 10.1128/jvi. 01138-17, 2018 | 19 | 2018 |
| Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING C Rueckert, U Rand, U Roy, B Kasmapour, T Strowig, CA Guzmán The FASEB Journal 31 (7), 3107-3115, 2017 | 19 | 2017 |
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD … F Bertoglio, V Fühner, M Ruschig, PA Heine, L Abasi, T Klünemann, ... BioRxiv, 2020.12. 03.409318, 2020 | 17 | 2020 |
| Uncoupling of the dynamics of host–pathogen interaction uncovers new mechanisms of viral interferon antagonism at the single-cell level U Rand, U Hillebrand, S Sievers, S Willenberg, M Köster, H Hauser, ... Nucleic acids research 42 (13), e109-e109, 2014 | 15 | 2014 |
| Single-cell transcriptional profiling of splenic fibroblasts reveals subset-specific innate immune signatures in homeostasis and during viral infection J Pezoldt, C Wiechers, F Erhard, U Rand, T Bulat, M Beckstette, ... Communications Biology 4 (1), 1355, 2021 | 14 | 2021 |
| A novel triple-fluorescent HCMV strain reveals gene expression dynamics and anti-herpesviral drug mechanisms U Rand, T Kubsch, B Kasmapour, L Cicin-Sain Frontiers in Cellular and Infection Microbiology 10, 536150, 2021 | 11 | 2021 |
| Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations. medRxiv 2021 H Jacobsen, M Strengert, H Maass, MAY Durand, B Kessel, M Harries Preprint]. doi 2021, 2021 | 10 | 2021 |
| Single‐cell analysis reveals heterogeneity in onset of transgene expression from synthetic tetracycline‐dependent promoters U Rand, J Riedel, U Hillebrand, D Shin, S Willenberg, S Behme, ... Biotechnology Journal 10 (2), 323-331, 2015 | 10 | 2015 |
Luka Čičin-Šainresearch Group Leaders, Helmholtz Centre for Infection ResearchBestätigte E-Mail-Adresse bei helmholtz-hzi.de
